108
Participants
Start Date
December 6, 2010
Primary Completion Date
June 1, 2015
Study Completion Date
July 17, 2020
Laboratory Biomarker Analysis
Correlative studies
Paclitaxel
Given IV
Pelareorep
Given IV
Carilion Clinic Gynecological Oncology, Roanoke
Wake Forest University Health Sciences, Winston-Salem
Atrium Health Cabarrus/LCI-Concord, Concord
Northeast Georgia Medical Center-Gainesville, Gainesville
University of Mississippi Medical Center, Jackson
Ohio State University Comprehensive Cancer Center, Columbus
UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor
Case Western Reserve University, Cleveland
Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
Hillcrest Hospital Cancer Center, Mayfield Heights
Cleveland Clinic Foundation, Cleveland
Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
Lake Huron Medical Center, Port Huron
Saint John Macomb-Oakland Hospital, Warren
Michigan Cancer Research Consortium NCORP, Ann Arbor
Saint Joseph Mercy Hospital, Ann Arbor
Beaumont Hospital - Dearborn, Dearborn
Saint Mary Mercy Hospital, Livonia
Ascension Saint John Hospital, Detroit
Saint Joseph Mercy Oakland, Pontiac
Genesys Regional Medical Center, Grand Blanc
Hurley Medical Center, Flint
Ascension Saint Mary's Hospital, Saginaw
Sparrow Hospital, Lansing
Allegiance Health, Jackson
Medical College of Wisconsin, Milwaukee
Mayo Clinic in Rochester, Rochester
University of Oklahoma Health Sciences Center, Oklahoma City
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Saint Alphonsus Cancer Care Center-Boise, Boise
University of New Mexico Cancer Center, Albuquerque
Women's Cancer Center of Nevada, Las Vegas
Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank
Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View
Smilow Cancer Hospital Care Center at Saint Francis, Hartford
Women and Infants Hospital, Providence
Collaborators (1)
NRG Oncology
OTHER
National Cancer Institute (NCI)
NIH